Difference between revisions of "Sorafenib Dosing Nomogram"
(Created page with "{{#lst:Section editor transclusions|peds}} <big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow Acute myeloid...") |
Warner-admin (talk | contribs) m (Text replacement - ":Section editor transclusions|" to ":Editorial board transclusions|") |
||
(7 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | {{#lst: | + | {{#lst:Editorial board transclusions|peds}} |
− | |||
{| class="wikitable" style="float:right; margin-right: 5px;" | {| class="wikitable" style="float:right; margin-right: 5px;" | ||
|- | |- | ||
Line 7: | Line 6: | ||
|} | |} | ||
{{TOC limit|limit=3}} | {{TOC limit|limit=3}} | ||
+ | |||
+ | =AAML1031 Sorafenib Dosing Nomogram= | ||
+ | ''Note: BSA is rounded to the hundredth place.'' | ||
+ | {| class="wikitable" style="width: 80%; text-align:center;" | ||
+ | ! style="width: 25%" |BSA Range (m<sup>2</sup>) | ||
+ | ! style="width: 25%" |Dose Level 0 (100 mg/m<sup>2</sup>/day once daily) | ||
+ | ! style="width: 25%" |Dose Level 1 (200 mg/m<sup>2</sup>/day once daily) | ||
+ | ! style="width: 25%" |Dose Level 2 (300 mg/m<sup>2</sup>/day divided twice per day) | ||
+ | |- | ||
+ | |Less than or equal to 0.35 | ||
+ | |50 mg x 4 days/week, | ||
+ | 0 x 3 day/week | ||
+ | (200 mg) | ||
+ | |50 mg x 5 days/week, | ||
+ | 100 mg x 2 days/week | ||
+ | (450 mg) | ||
+ | |50 mg twice per day x 7 days/week | ||
+ | (700 mg) | ||
+ | |- | ||
+ | |0.36 to 0.40 | ||
+ | |50 mg x 5 days/week, | ||
+ | 0 x 2 day/week | ||
+ | (250 mg) | ||
+ | |50 mg x 4 days/week, | ||
+ | 100 mg x 3 days/week | ||
+ | (500 mg) | ||
+ | |50 mg twice per day x 6 days/week + | ||
+ | 100 mg twice per day x 1 day/week | ||
+ | (800 mg) | ||
+ | |- | ||
+ | |0.41 to 0.45 | ||
+ | |50 mg x 6 days/week, | ||
+ | 0 x 1 day/week | ||
+ | (300 mg) | ||
+ | |50 mg x 2 days/week, | ||
+ | 100 mg x 5 days/week | ||
+ | (600 mg) | ||
+ | |50 mg twice per day x 5 days/week + | ||
+ | 100 mg twice per day x 2 days/week | ||
+ | (900 mg) | ||
+ | |- | ||
+ | |0.46 to 0.55 | ||
+ | |50 mg x 7 days/week | ||
+ | (350 mg) | ||
+ | |100 mg x 7 days/week | ||
+ | (700 mg) | ||
+ | |50 mg q AM +100 mg q PM | ||
+ | x 7 days/week | ||
+ | (1050 mg) | ||
+ | |- | ||
+ | |0.56 to 0.60 | ||
+ | |50 mg x 6 days/week, | ||
+ | 100 mg x 1 day/week | ||
+ | (400 mg) | ||
+ | |100 mg x 6 days/week, | ||
+ | 200 mg x 1 day/week | ||
+ | (800 mg) | ||
+ | |50 mg twice per day x 2 days/week + | ||
+ | 100 mg twice per day x 5 days/week | ||
+ | (1200 mg) | ||
+ | |- | ||
+ | |0.61 to 0.70 | ||
+ | |50 mg x 5 days/week, | ||
+ | 100 mg x 2 days/week | ||
+ | (450 mg) | ||
+ | |100 mg x 5 days/week, | ||
+ | 200 x 2 days/week | ||
+ | (900 mg) | ||
+ | |100 mg twice per day x 7 days/week | ||
+ | (1400 mg) | ||
+ | |- | ||
+ | |0.71 to 0.80 | ||
+ | |50 mg x4 days/week, | ||
+ | 100 mg x3 days/week | ||
+ | (500 mg) | ||
+ | |150 mg x 7 days/week | ||
+ | (1050mg) | ||
+ | |100 mg twice per day x 5 days/week + | ||
+ | 150 mg twice per day x 2 days/week | ||
+ | (1600 mg) | ||
+ | |- | ||
+ | |0.81 to 0.90 | ||
+ | |50 mg x 2 days/week, | ||
+ | 100 mg x 5 days/week | ||
+ | (600 mg) | ||
+ | |150 mg x 4 days/week, | ||
+ | 200 mg x 3 | ||
+ | days/week | ||
+ | (1200 mg) | ||
+ | |100 mg q AM + 150 mg q PM | ||
+ | x 7 days/week | ||
+ | (1750 mg) | ||
+ | |- | ||
+ | |0.91 to 1.05 | ||
+ | |100 mg x 7 days/week | ||
+ | (700 mg) | ||
+ | |200 mg x 7 days/week | ||
+ | (1400 mg) | ||
+ | |150 mg twice per day x 7 days/week | ||
+ | (2100 mg) | ||
+ | |- | ||
+ | |1.06 to 1.20 | ||
+ | |100 mg x 6 days/week, | ||
+ | 200 mg x1 day/week | ||
+ | (800 mg) | ||
+ | |200 | ||
+ | mg x 3 days/week, | ||
+ | 250 mg x 4 days/week | ||
+ | (1600 mg) | ||
+ | |150 mg q AM + 200 mg q PM | ||
+ | x 7 days/week | ||
+ | (2450 mg) | ||
+ | |- | ||
+ | |1.21 to 1.35 | ||
+ | |100 mg x 5 days/week, | ||
+ | 200 mg x 2 days/week | ||
+ | (900 mg) | ||
+ | |250 mg x 7 days/week | ||
+ | (1750 mg) | ||
+ | |200 mg twice per day x 7 days/week | ||
+ | (2800 mg) | ||
+ | |- | ||
+ | |1.36 to 1.60 | ||
+ | |100 mg x 4 days/week, | ||
+ | 200 mg x 3 days/week | ||
+ | (1000 mg) | ||
+ | |300 mg x 7 days/week | ||
+ | (2100 mg) | ||
+ | |200 mg q AM + 250 mg q PM | ||
+ | x 7 days/week | ||
+ | (3150 mg) | ||
+ | |- | ||
+ | |1.61 to 1.70 | ||
+ | |100 mg x 2 days/week, | ||
+ | 200 mg x 5 days/week | ||
+ | (1200 mg) | ||
+ | |350 mg x 7 days/week | ||
+ | (2450 mg) | ||
+ | |250 mg twice per day x 7 | ||
+ | days/week | ||
+ | (3500 mg) | ||
+ | |- | ||
+ | |1.71 to 1.85 | ||
+ | |100 mg x 1 day/week, | ||
+ | 200 mg x 6 days/week | ||
+ | (1300 mg) | ||
+ | |350 mg x 3 days/week | ||
+ | 400 mg x 4 days/week | ||
+ | (2650 mg) | ||
+ | |250 mg q AM + 300 mg q PM | ||
+ | x 7 days/week | ||
+ | (3850 mg) | ||
+ | |- | ||
+ | |1.86 or more | ||
+ | |200 mg x 7 days/week | ||
+ | (1400 mg) | ||
+ | |400 mg x 7 days/week | ||
+ | (2800 mg) | ||
+ | |300 mg twice per day x 7 days /week | ||
+ | (4200 mg) | ||
+ | |} | ||
+ | |||
+ | [[Category:General reference pages]] | ||
+ | [[Category:Clinical pharmacology]] |
Latest revision as of 20:21, 11 August 2023
Section editor | |
---|---|
David Noyd, MD, MPH University of Washington Seattle, WA, USA |
0 regimens on this page
0 variants on this page
|
AAML1031 Sorafenib Dosing Nomogram
Note: BSA is rounded to the hundredth place.
BSA Range (m2) | Dose Level 0 (100 mg/m2/day once daily) | Dose Level 1 (200 mg/m2/day once daily) | Dose Level 2 (300 mg/m2/day divided twice per day) |
---|---|---|---|
Less than or equal to 0.35 | 50 mg x 4 days/week,
0 x 3 day/week (200 mg) |
50 mg x 5 days/week,
100 mg x 2 days/week (450 mg) |
50 mg twice per day x 7 days/week
(700 mg) |
0.36 to 0.40 | 50 mg x 5 days/week,
0 x 2 day/week (250 mg) |
50 mg x 4 days/week,
100 mg x 3 days/week (500 mg) |
50 mg twice per day x 6 days/week +
100 mg twice per day x 1 day/week (800 mg) |
0.41 to 0.45 | 50 mg x 6 days/week,
0 x 1 day/week (300 mg) |
50 mg x 2 days/week,
100 mg x 5 days/week (600 mg) |
50 mg twice per day x 5 days/week +
100 mg twice per day x 2 days/week (900 mg) |
0.46 to 0.55 | 50 mg x 7 days/week
(350 mg) |
100 mg x 7 days/week
(700 mg) |
50 mg q AM +100 mg q PM
x 7 days/week (1050 mg) |
0.56 to 0.60 | 50 mg x 6 days/week,
100 mg x 1 day/week (400 mg) |
100 mg x 6 days/week,
200 mg x 1 day/week (800 mg) |
50 mg twice per day x 2 days/week +
100 mg twice per day x 5 days/week (1200 mg) |
0.61 to 0.70 | 50 mg x 5 days/week,
100 mg x 2 days/week (450 mg) |
100 mg x 5 days/week,
200 x 2 days/week (900 mg) |
100 mg twice per day x 7 days/week
(1400 mg) |
0.71 to 0.80 | 50 mg x4 days/week,
100 mg x3 days/week (500 mg) |
150 mg x 7 days/week
(1050mg) |
100 mg twice per day x 5 days/week +
150 mg twice per day x 2 days/week (1600 mg) |
0.81 to 0.90 | 50 mg x 2 days/week,
100 mg x 5 days/week (600 mg) |
150 mg x 4 days/week,
200 mg x 3 days/week (1200 mg) |
100 mg q AM + 150 mg q PM
x 7 days/week (1750 mg) |
0.91 to 1.05 | 100 mg x 7 days/week
(700 mg) |
200 mg x 7 days/week
(1400 mg) |
150 mg twice per day x 7 days/week
(2100 mg) |
1.06 to 1.20 | 100 mg x 6 days/week,
200 mg x1 day/week (800 mg) |
200
mg x 3 days/week, 250 mg x 4 days/week (1600 mg) |
150 mg q AM + 200 mg q PM
x 7 days/week (2450 mg) |
1.21 to 1.35 | 100 mg x 5 days/week,
200 mg x 2 days/week (900 mg) |
250 mg x 7 days/week
(1750 mg) |
200 mg twice per day x 7 days/week
(2800 mg) |
1.36 to 1.60 | 100 mg x 4 days/week,
200 mg x 3 days/week (1000 mg) |
300 mg x 7 days/week
(2100 mg) |
200 mg q AM + 250 mg q PM
x 7 days/week (3150 mg) |
1.61 to 1.70 | 100 mg x 2 days/week,
200 mg x 5 days/week (1200 mg) |
350 mg x 7 days/week
(2450 mg) |
250 mg twice per day x 7
days/week (3500 mg) |
1.71 to 1.85 | 100 mg x 1 day/week,
200 mg x 6 days/week (1300 mg) |
350 mg x 3 days/week
400 mg x 4 days/week (2650 mg) |
250 mg q AM + 300 mg q PM
x 7 days/week (3850 mg) |
1.86 or more | 200 mg x 7 days/week
(1400 mg) |
400 mg x 7 days/week
(2800 mg) |
300 mg twice per day x 7 days /week
(4200 mg) |